Vice Provost and Dean of Research
Showing 81-100 of 127 Results
-
Luigi Pistaferri
Ray Lyman Wilbur Professor and Senior Fellow at the Stanford Institute for Economic Policy Research
BioLuigi Pistaferri is a Professor of Economics at Stanford University, a research fellow of NBER, CEPR and IZA, the "Ralph Landau" Senior Fellow at SIEPR, and one of the co-editors of the American Economic Review. His papers are on the intersection between labor economics and macroeconomics. Pistaferri holds a PhD in Economics from University College, London, and a Doctorate in Economic Sciences from IUN in Naples (Italy), where he was born in 1968. Pistaferri joined Stanford University in 1999 after finishing his PhD and has been a member of the faculty ever since, with the exception of one year sabbatical spent at EIEF in Rome.
-
Sharon Pitteri
Professor (Research) of Radiology (Diagnostic Sciences Laboratory)
Current Research and Scholarly InterestsThe Pitteri laboratory is focused on the discovery and validation of proteins that can be used as molecular indicators of risk, diagnosis, progression, and recurrence of cancer. Proteomic technologies, predominantly mass spectrometry, are used to identify proteins in the blood that are differentially regulated and/or post-translationally modified with disease state. Using human plasma samples, tumor tissue, cancer cell lines, and genetically engineered mouse models, the origins of these proteins are being investigated. A major goal of this research is to define novel molecular signatures for breast and ovarian cancers, including particular sub-types of these diseases. This laboratory is also focused on the identification of proteins with expression restricted to the surface of cancer cells which can be used as novel targets for molecular imaging technologies.
-
Tino Pleiner
Assistant Professor of Molecular and Cellular Physiology
Current Research and Scholarly InterestsThe Pleiner lab combines mechanistic cell biology, structural biochemistry and protein engineering to dissect the pathways and molecular machines that mature human membrane proteins to a fully functional state. We also develop alpaca-derived and synthetic nanobodies as tools to modulate intracellular pathways that globally regulate protein homeostasis in health and disease.
-
Sylvia K. Plevritis, PhD
William M. Hume Professor in the School of Medicine, Professor of Biomedical Data Science and of Radiology
Current Research and Scholarly InterestsMy research program focuses on computational modeling of cancer biology and cancer outcomes. My laboratory develops stochastic models of the natural history of cancer based on clinical research data. We estimate population-level outcomes under differing screening and treatment interventions. We also analyze genomic and proteomic cancer data in order to identify molecular networks that are perturbed in cancer initiation and progression and relate these perturbations to patient outcomes.
-
Jim Plummer
John M. Fluke Professor of Electrical Engineering, Emeritus
Current Research and Scholarly InterestsGenerally studies the governing physics and fabrication technology of silicon integrated circuits, including the scaling limits of silicon technology, and the application of silicon technology outside traditional integrated circuits, including power switching devices such as IGBTs. Process simulation tools like SUPREM for simulating fabrication. Recent work has focused on wide bandgap semiconductor materials, particularly SiC and GaN, for power control devices.
-
Kilian M. Pohl, PhD
Professor (Research) of Psychiatry and Behavioral Sciences (Major Labs and Incubator) and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsThe foundation of the laboratory is computational science aimed at identifying biomedical phenotypes improving the mechanistic understanding, diagnosis, and treatment of neuropsychiatric disorders. The biomedical phenotypes are discovered by unbiased, machine learning-based searches across biological, neuroimaging, and neuropsychological data. This data-driven discovery currently supports the adolescent brain research of the NIH-funded National Consortium on Alcohol and NeuroDevelopment in Adolescence (NCANDA). The laboratory also investigates brain patterns specific to alcohol use disorder, depression, and the human immunodeficiency virus (HIV) across the adult age range, and have advanced the understanding of a variety of brain diseases including schizophrenia, Alzheimer’s disease, glioma, and aging.
-
Mary Polan
Katharine Dexter McCormick and Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsDr. Polan's research has centered around ovarian function during both the follicular and luteal phases. Studies of steroidogenesis, LH receptor synthesis, and the involvement of the plasminogen activator system in ovarian events have been performed.
-
Russell Poldrack
Albert Ray Lang Professor of Psychology and, by courtesy, of Psychiatry and Behavioral Science
Current Research and Scholarly InterestsOur lab uses the tools of cognitive neuroscience to understand how decision making, executive control, and learning and memory are implemented in the human brain. We also develop neuroinformatics tools and resources to help researchers make better sense of data.
-
Jonathan Pollack
Professor of Pathology
Current Research and Scholarly InterestsResearch in the Pollack lab centers on translational genomics, with a focus on prostate diseases. The lab employs next-generation sequencing, single-cell and spatial genomics, gene editing, and human cell/tissue-based modeling to uncover disease mechanisms, biomarkers and therapeutic targets. Current areas of emphasis include benign prostatic hyperplasia, prostate cancer, and rare/neglected cancer types (ameloblastoma, liposarcoma).
-
Elizabeth Ponder
Executive Director, Sarafan ChEM-H
BioElizabeth Ponder is a recognized leader in innovation and translation at the non-profit / for profit interface. Ponder has spent 15+ years building and scaling high-impact research organizations at the intersection of biomedical innovation, global health, and drug development — focused on ensuring the human health impact of transformative scientific discoveries while fostering the next generation of scientists.
As Executive Director of Sarafan ChEM-H, Ponder leads the institute's efforts to drive academic innovation and training at the interface of molecular disciplines. Ponder oversees Sarafan ChEM-H's research, education, and translational programs, guiding initiatives that foster collaboration, innovation, and impact.
With over a decade at Stanford, Ponder has changed the landscape of interdisciplinary molecular research and training. Under her leadership, the institute recruited 19 faculty representing the “scientific maverick” phenotype from diverse fields of molecular research, including 2022 Nobel Prize laureate Carolyn Bertozzi; established an innovative Ph.D. training program (NIH and philanthropy-funded) serving 150+ doctoral trainees since 2015; and designed and opened a 235,000 sq ft interdisciplinary research complex to house the institute. Her responsibilities include oversight of strategy, planning, and operations for the institute.
Most recently, Ponder oversaw the design and implementation of the “Nucleus" as a scalable model for democratizing access to cutting-edge research technologies and expertise and leveraged the Nucleus infrastructure to support a 6-year pilot program for strategic translational investments in new medicines based on Stanford discoveries, the Stanford Innovative Medicines Accelerator. The Nucleus has touched more than 600 research projects in 200+ faculty labs across the Stanford campus contributing to patents, publications, and new grant funding. The translational portfolio included 135+ projects, 8 successful exits to VC-backed biotechnology companies, and 9 clinical trials of experimental therapeutics, including 2 first-in-human trials of experimental therapeutics discovered and developed entirely within Stanford. Ponder also played a critical role in external relationship management for the portfolio, ranging from key philanthropic donors to biopharmaceutical partners and venture capital investors.
Ponder was recognized for leadership excellence at Stanford through selection for Leadership@Stanford (2025 cohort) and the 2023 Marsh O'Neill Award for exceptional support of Stanford's research enterprise.
Before joining Stanford, Ponder led policy, research, and training initiatives at the global health - biopharmaceutical industry interface. She served as Executive Director of the Wheeler Center for Emerging & Neglected Diseases at UC Berkeley where she designed and launched new programs addressing neglected disease research. She also served in roles of increasing responsibility in Scientific Affairs at BIO Ventures for Global Health (BVGH), where she provided scientific leadership to project teams and executive leadership, advancing BVGH's mission to increase innovative biotech participation in drug, vaccine, and diagnostic development for neglected diseases of the developing world.
Ponder completed her Ph.D. and postdoctoral research at Stanford in the department of microbiology and immunology, supported by an NSF National Science Foundation Graduate Research Fellowship and Stanford Dean’s postdoctoral fellowship. She published multiple peer-reviewed scientific publications focused on protease function and drug target potential in Plasmodium falciparum, the parasite that causes human malaria. Her early work in infectious diseases inspired her life-long passion for improving human health through scientific innovation. -
Ada Poon
Associate Professor of Electrical Engineering
Current Research and Scholarly InterestsOur research focuses on providing theoretical foundations and engineering platforms for realizing electronics that seamlessly integrate with the body. Such systems will allow precise recording or modulation of physiological activity, for advancing basic scientific discovery and for restoring or augmenting biological functions for clinical applications.
-
Eric Pop
Pease-Ye Professor, Professor of Electrical Engineering, Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Materials Science and Engineering and of Applied Physics
Current Research and Scholarly InterestsThe Pop Lab explores problems at the intersection of nanoelectronics and nanoscale energy conversion. These include fundamental limits of current and heat flow, energy-efficient transistors and memory, and energy harvesting via thermoelectrics. The Pop Lab also works with novel nanomaterials like carbon nanotubes, graphene, BN, MoS2, and their device applications, through an approach that is experimental, computational and highly collaborative.
-
Richard Popp
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsAcademic-Industrial relations; Ethics of invention.
